Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Silo Pharma Inc (OP: SILO )

N/A UNCHANGED
Last Price Updated: 3:23 PM EDT, Sep 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Silo Pharma Inc

< Previous 1 2 3 4 Next >
Illinois Advocates Prepare to Introduce First Psychedelics Measure
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Announces Milestone in Psilocybin Study on Parkinson’s Patients
Via Investor Brand Network
FDA Expands Access to MDMA for Treatment of PTSD
Via Investor Brand Network
Exposures Product Safety
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) CEO Featured in Bell2Bell Podcast Episode
Via Investor Brand Network
First Psychedelic Trial Clinic Set to Launch in London
Via Investor Brand Network
Silo Pharma Inc. (SILO) Spotlight: Ketamine
Via Investor Brand Network
Silo Pharma Inc. (SILO) Spotlight: Ketamine
Via Investor Brand Network
Researchers Have Found Brain Cells That Die Due to Parkinson’s Disease
Via Investor Brand Network
Study Finds Service Dogs Help Individuals with PTSD
Via Investor Brand Network
3 Psychedelic Documentaries You Can Watch on YouTube
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO), Frontage Laboratories to Collaborate in Pharmacokinetic Study
Via Investor Brand Network
New Study Sheds Light on Inflammation Linked to COVID-19
Via Investor Brand Network
Exposures COVID-19
Studies Find Link Between ADHD, Fibromyalgia
Via Investor Brand Network
Research Highlights the High Economic Cost of PTSD
Via Investor Brand Network
Advocates Urge Use of Alternative Treatments to Curb Veteran Suicides
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Focusing on Largely Underserved Indications
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Study Evalutes Possible Link Between Parkinson’s Disease, Autoimmune Malfunction
Via Investor Brand Network
Study Finds That Psychedelics Free Up Brains of Individuals with Depression
Via Investor Brand Network
Silo Pharma Inc. (SILO) Advances with Pharmacokinetic Study – but What is Pharmacokinetics?
Via Investor Brand Network
Scientists Stop Memory Decay by Administering Nasal Therapy to Mice
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Produces First Batch of SPU-21 Liposomes for RA Study
Via Investor Brand Network
Silo Pharma Inc. (SILO) Emerging Leader as Psychedelics ‘on the Cusp of Entering Mainstream Psychiatry’
Via Investor Brand Network
BioMedNewsBreaks – Why Silo Pharma Inc. (SILO) Is ‘One to Watch’
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Enters Agreement to Significantly Advance Technologies ‘Closer to the Clinic’
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Initiates Coverage with InvestorBrandNetwork
Via Investor Brand Network
Silo Pharma Inc. (SILO) Is ‘One to Watch’
Via Investor Brand Network
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
Via Benzinga
Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer's Disease
Agreement Provides for Option to License Alzheimer’s Therapeutic Englewood Cliffs, NJ, October 27, 2021 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage... 
Via Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
The Week In Psychedelics 
Via Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.